DRH1 – a novel blood-based HPV tumour marker

BACKGROUND: To date, no studies have successfully shown that a highly specific, blood-based tumour marker to detect clinically relevant HPV-induced disease could be used for screening, monitoring therapy response or early detection of recurrence. This study aims to assess the clinical performance of...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiland, Thomas, Eckert, Alexander, Tomazic, Peter Valentin, Wolf, Axel, Pondorfer, Prisca, Vasicek, Sarah, Graupp, Matthias, Holzmeister, Clemens, Moser, Ulrich, Andrianakis, Alexandros, Kangler, Georg, Kiss, Peter, Brcic, Luka, Kappler, Matthias, Wickenhauser, Claudia, Haak, Anja, Krüger, Maximilian, Al-Nawas, Bilal, Blatt, Sebastian, Brockmeyer, Norbert, Skaletz-Rorowski, Adriane, Potthoff, Anja, French, Lars E., Charnowski, Sara, Reinholz, Markus, Kaufmann, Andreas M., Thies, Sarah, Lambrecht, Hans-Georg, Seliger, Barbara, Wild, Dominik C., Thurnher, Dietmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300133/
https://www.ncbi.nlm.nih.gov/pubmed/32535546
http://dx.doi.org/10.1016/j.ebiom.2020.102804

Ejemplares similares

Ejemplares similares